We have located links that may give you full text access.
Ocular findings in patients with psoriasis: Is it related to the side effects of treatment or to psoriasis itself? A case-control study.
Journal of Dermatological Treatment 2019 Februrary 2
OBJECTIVES: To assess ocular abnormalities in psoriatic patients (new-cases vs. patients under treatment) in comparison with healthy controls.
METHODS: A total of 200 psoriatic patients and 100 healthy controls were enrolled in this prospective, observational study. The demographic data of the individuals were recorded. Dermatological and ophthalmological examinations were conducted; ocular surface disease index (OSDI), Schirmer and tear break-up time (TBUT) values were also measured.
RESULTS: The mean values of TBUT and Schirmer tests in patients were significantly lower than the controls and significantly higher scores of OSDI were observed among patients compared to the controls (p<.0001); dry eye disease was more frequent in the patients than the healthy subjects (p=.001). Other ocular findings including cataract and uveitis were not significantly different between the groups. Although no significant differences were found between the ocular findings of new cases and patients under treatment, ocular findings in cases under treatment were associated with the type of treatment and more frequent in those treated with methotrexate, followed by acitretin and biologic drugs.
CONCLUSIONS: Ocular surface problems in psoriatic patients are more common than previously thought; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play an important role.
KEY POINTS: There are limited case-control studies about ocular manifestations in psoriasis and also its pathogenesis is not yet clear. This study shows that ocular surface problems in psoriatic patients are higher than healthy subjects; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play a pivotal role. Regular ophthalmological evaluations are recommended in psoriatic patients especially those with more severe and chronic form of the disease, to prevent any complications.
METHODS: A total of 200 psoriatic patients and 100 healthy controls were enrolled in this prospective, observational study. The demographic data of the individuals were recorded. Dermatological and ophthalmological examinations were conducted; ocular surface disease index (OSDI), Schirmer and tear break-up time (TBUT) values were also measured.
RESULTS: The mean values of TBUT and Schirmer tests in patients were significantly lower than the controls and significantly higher scores of OSDI were observed among patients compared to the controls (p<.0001); dry eye disease was more frequent in the patients than the healthy subjects (p=.001). Other ocular findings including cataract and uveitis were not significantly different between the groups. Although no significant differences were found between the ocular findings of new cases and patients under treatment, ocular findings in cases under treatment were associated with the type of treatment and more frequent in those treated with methotrexate, followed by acitretin and biologic drugs.
CONCLUSIONS: Ocular surface problems in psoriatic patients are more common than previously thought; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play an important role.
KEY POINTS: There are limited case-control studies about ocular manifestations in psoriasis and also its pathogenesis is not yet clear. This study shows that ocular surface problems in psoriatic patients are higher than healthy subjects; in addition to the role of treatment modalities, psoriasis itself and a probable systemic inflammation may play a pivotal role. Regular ophthalmological evaluations are recommended in psoriatic patients especially those with more severe and chronic form of the disease, to prevent any complications.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app